Detalhe da pesquisa
1.
Comparison of JAK2V617F -positive essential thrombocythaemia and early primary myelofibrosis: The impact of mutation burden and histology.
Hematol Oncol
; 36(1): 269-275, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28509339
2.
Clinical results according to age in patients with chronic myeloid leukemia receiving imatinib frontline: The younger, the later, the worse?
Eur J Haematol
; 2018 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-29896890
3.
Impact of exclusion criteria for the DASISION and ENESTnd trials in the front-line treatment of a 'real-life' patient population with chronic myeloid leukaemia.
Hematol Oncol
; 35(2): 232-236, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26648184
4.
Risk factors for infections in myelofibrosis: role of disease status and treatment. A multicenter study of 507 patients.
Am J Hematol
; 92(1): 37-41, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27701770
5.
Nilotinib 300 mg twice daily: an academic single-arm study of newly diagnosed chronic phase chronic myeloid leukemia patients.
Haematologica
; 101(10): 1200-1207, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27470600
6.
Chelation efficacy and erythroid response during deferasirox treatment in patients with myeloproliferative neoplasms in fibrotic phase.
Eur J Haematol
; 96(6): 643-9, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26277477
7.
Spleen enlargement is a risk factor for thrombosis in essential thrombocythemia: Evaluation on 1,297 patients.
Am J Hematol
; 91(3): 318-21, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26748894
8.
Rotation of nilotinib and imatinib for first-line treatment of chronic phase chronic myeloid leukemia.
Am J Hematol
; 91(6): 617-22, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26971721
9.
Personal history and quality of life in chronic myeloid leukemia patients: a cross-sectional study using narrative medicine and quantitative analysis.
Support Care Cancer
; 24(11): 4487-93, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27260015
10.
Long-term outcome of a phase 2 trial with nilotinib 400 mg twice daily in first-line treatment of chronic myeloid leukemia.
Haematologica
; 100(9): 1146-50, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26113419
11.
Application of systematic coronary risk evaluation chart to identify chronic myeloid leukemia patients at risk of cardiovascular diseases during nilotinib treatment.
Ann Hematol
; 94(3): 393-7, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25304102
12.
An increase in hemoglobin, platelets and white blood cells levels by iron chelation as single treatment in multitransfused patients with myelodysplastic syndromes: clinical evidences and possible biological mechanisms.
Ann Hematol
; 94(5): 771-7, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25743685
13.
Incidence of persistent/late chronic anemia in newly diagnosed patients with chronic myeloid leukemia responsive to imatinib.
Am J Hematol
; 90(2): 105-8, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25349084
14.
Catheter-associated bloodstream infections and thrombotic risk in hematologic patients with peripherally inserted central catheters (PICC).
Support Care Cancer
; 23(11): 3289-95, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25910751
15.
Deferasirox for transfusion-dependent patients with myelodysplastic syndromes: safety, efficacy, and beyond (GIMEMA MDS0306 Trial).
Eur J Haematol
; 92(6): 527-36, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24580147
16.
Thrombosis and survival in essential thrombocythemia: a regional study of 1,144 patients.
Am J Hematol
; 89(5): 542-6, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24481665
17.
Long term outcome of Ph+ CML patients achieving complete cytogenetic remission with interferon based therapy moving from interferon to imatinib era.
Am J Hematol
; 89(2): 119-24, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24122886
18.
Body mass index does not impact on molecular response rate of chronic myeloid leukaemia patients treated frontline with second generation tyrosine kinase inhibitors.
Br J Haematol
; 182(3): 427-429, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28677850
19.
Frontline imatinib treatment of chronic myeloid leukemia: no impact of age on outcome, a survey by the GIMEMA CML Working Party.
Blood
; 117(21): 5591-9, 2011 May 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-21450900
20.
Health-related quality of life in chronic myeloid leukemia patients receiving long-term therapy with imatinib compared with the general population.
Blood
; 118(17): 4554-60, 2011 Oct 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-21750313